Pneumococcal Adult and At Risk Vaccination Programme 2026/28

Purpose and outline

This programme delivers vaccinations for patients aged 65 or over and at-risk patients aged 10 years to 64 years inclusive. Pneumococcal vaccines protect against pneumococcal infections. Invasive pneumococcal disease is a major cause of morbidity and mortality; whilst it can affect anyone, it particularly affects the very young, the elderly and those with impaired immunity or chronic conditions.

The Pneumococcal Polysaccharide Vaccine PPV23 will be replaced with Pneumococcal Conjugate Vaccine PCV20 once existing stocks have depleted, which is estimated to be during 2026.

PPV23 and PCV20 are the only vaccines routinely recommended for the patients eligible under this programme (PCV13 is offered to children as part of the Routine Immunisation schedules) and only one dose is usually required per patient which usually provides life-time cover. For a small number of at-risk patients, vaccination every five years is required.

How this service is commissioned and provided

Region’s commission this service from GP practices.

2026/28: Information about this service

Quality service start date: 1 April 2026

Quality service end date: 31 March 2028

Payment period: Monthly

Collection frequency: Monthly

Manual or automatic entry: Automatic data collection

Included in data collection: All system suppliers (TPP, Medicus and EMIS)

System type: Vaccination and Immunisation (V&I)

Service user guides

The below link to user guides describing how to participate, manually enter and declare achievement for this service:

Viewing, accepting and rejecting a Quality service offered in CQRS National

Manually inputting Achievement data

Declaring an achievement for payment

Pneumococcal Children and At Risk Vaccination Programme 2026-28

Purpose and outline

Routine immunisation with recommended pneumococcal vaccine for infants born on or after January 1, 2020, includes:

  • A single dose at 16 weeks of age.
  • A booster dose at 1 year old (on or after their first birthday).

For unimmunised or partially immunised children presenting late for vaccination before age 1, administer a single priming dose of recommended pneumococcal vaccine, followed by a booster at 1 year of age (on or after their first birthday), at least 4 weeks after the first dose.

Children aged 1 year to under 2 years who are unimmunised or partially immunised should receive a single dose of recommended pneumococcal vaccine.

Routine immunisation with pneumococcal vaccine is not offered after the second birthday.

Additional recommended doses will be offered to those at risk or immunocompromised.

Recommended vaccine products are detailed within the Green Book Chapter 25.

How this service is commissioned and provided

Region’s commission this service from GP practices.

2026/28: Information about this service

Quality service start date: 1 April 2026

Quality service end date: 31 March 2028

Payment period: Monthly

Collection frequency: Monthly

Manual or automatic entry: Automatic data collection

Included in data collection: All system suppliers (TPP, Medicus and EMIS)

System type: Vaccination and Immunisation (V&I)

Service user guides

The below link to user guides describing how to participate, manually enter and declare achievement for this service:

Viewing, accepting and rejecting a Quality service offered in CQRS National

Manually inputting Achievement data

Declaring an achievement for payment

PSA Monitoring

Purpose and outline

A Prostate-specific-antigen (PSA) is a blood test to check for prostate conditions.

Information about this service

Local incentive scheme.

Example components for this service

Prostate Scheme inhouse Urology First Appointment.

Prostate Scheme inhouse Urology Follow-up Appointment.

Prostate Scheme inhouse Urology in-house First Appointment and Domiciliary Visit.

Prostate Scheme inhouse Urology in-house Follow-up Appointment and Domiciliary Visit.

Declaration.

Prescribing Incentive Scheme

Information about this service

Local incentive scheme.

Example components for this service

Number of meetings.

Prescribing targets met.

Declaration.

Primary Care Offer

Information about this service

Local incentive scheme.

Example components for this service

Number of services offered.

Declaration.

Prostate Cancer

Purpose and outline

Prostate Cancer is a cancer of the prostate. Various tests help identify prostate cancer. Read more on the NHS website.

Information about this service

Local incentive scheme.

Example components for this service

Prostate Scheme inhouse Urology First Appointment.

Prostate Scheme inhouse Urology Follow-up Appointment.

Prostate Scheme inhouse Urology in-house First Appointment and Domiciliary Visit.

Prostate Scheme inhouse Urology in-house Follow-up Appointment and Domiciliary Visit.

Declaration.

Proactive Healthcare

Information about this service

Local incentive scheme.

Example components for this service

Prevention consultations with nurse practitioner.

Prevention consultations with GP.

Declaration.

Palliative Care

Purpose and outline

Palliative Care refers to end of life care given to patients, family and carers. GP and primary care healthcare professionals may be involved in end of life care. Read more on the NHS website.

Information about this service

Local incentive scheme.

Example components for this service

Number of hospice referrals.

Declaration.

Patient Engagement

Information about this service

Local incentive scheme.

Example components for this service

Number of meetings to discuss Patient Engagement improvement methods.

Time in hours spent on creating engagement systems and analysis.

Declaration.

Phlebotomy

Purpose and outline

Phlebotomy relates to the drawing of blood using a needle. It is a common procedure undertaken in GP practices for diagnostic testst.

Information about this service

Local incentive scheme.

Example components for this service

Total number of samples taken.

Total number of clinics cancelled.

Total number of clinics held.

Total number of patients seen at each clinic.

Declaration.

Post Operative Care

Information about this service

Local incentive scheme.

Example components for this service

Number of suture removals performed.

Number of wound dressings applied.

Number of one off injections administered.

Declaration.

Pre Operative Care

Information about this service

Local incentive scheme.

Example components for this service

Number of Examinations / Tests.

Number of GORH Agonist treatments administered.

Number of blood samples taken.

Number of urine tests conducted.

Number of blood pressure checks.

Declaration.

PCV Hib/Men C Vaccination Programme 2025-2026

Purpose and outline

Routine immunization with PCV13 for infants born on or after January 1, 2020, includes:

  • A single dose at 12 weeks of age.
  • A booster dose at 1 year old (on or after their first birthday).

For unimmunized or partially immunized children presenting late for vaccination before age 1, administer a single priming dose of PCV13, followed by a booster at 1 year of age (on or after their first birthday), at least 4 weeks after the first dose.

Children aged 1 year to under 2 years who are unimmunized or partially immunized should receive a single dose of PCV13. Routine immunization with PCV is not offered after the second birthday.

HiB/MenC Booster Programme: The JCVI announced the discontinuation of Menitorix (Hib/MenC) due to a commercial decision by the manufacturer. Current UK stocks can support the routine schedule until mid-2025.

How this service is commissioned and provided

Regions commission this service for GP practices.

NHS England service specifications

2025/26: Information about this service

Quality service start date: 1 April 2025

Quality service end date: 31 March 2026

Payment period: Monthly

Collection frequency: Monthly

Manual or automatic entry: Automatic data collection

Included in data collection: All system suppliers (TPP, Medicus and EMIS)

System type: Vaccination and Immunisation (V&I)

Service user guides

The Calculating Quality Reporting Service (CQRS) user guides describe how to participate, manually enter and declare achievement for this service.

Pertussis in Pregnant Women Vaccination Programme 2025-2028

Purpose and outline

The purpose of the service specification is to enable NHS England to commission pertussis in pregnant women immunisation services of sufficient quantity and quality to prevent the infections and outbreaks caused by these organisms.

The JCVI advised that pertussis in pregnant women vaccination programme should be extended for at least 5 years. JCVI considered that immunisation could be offered at one of the routine antenatal appointments and that immunisation within weeks 16 to 32 of pregnancy is likely to be optimal. Immunisation within weeks 16 to 38 of pregnancy may ensure greater overlap between the period of maximal antibody levels in the pregnant woman and the period of trans placental antibody transfer. Offering immunisation from 28 weeks would provide some protection to infants born prematurely who may be particularly vulnerable to complications from pertussis.

How this service is commissioned and provided

Regions commission this service from GP practices.

NHS England service specifications

2025/28: Information about this service

  • Quality service start date: 1 April 2025
  • Quality service end date: 31 March 2028
  • Payment period: Monthly
  • Collection frequency: Monthly
  • Manual or automatic entry: Automatic data collection
  • Included in data collection: All system suppliers (TPP, Medicus and EMIS)
  • System type: Vaccination and Immunisation (V&I)

Service user guides

The Calculating Quality Reporting Service (CQRS) user guides describe how to participate, manually enter and declare achievement for this service.

Physical health checks for people with severe mental illness 2019-2029

Background

NHS England and NHS Improvement is committed to leading work to ensure that “by 2020-21, 280,000 people living with SMI have their physical health needs met by increasing early detection and expanding access to evidence-based physical care assessment and intervention each year”. This equates to a target of 60% of people on the General Practice SMI register receiving a full and comprehensive physical health check across primary and secondary care. To ensure monitoring drives the right clinical behaviour, it is crucial that NHSE and NHSI is able to monitor delivery of the full comprehensive health check and to collect benchmarking information on the uptake of the corresponding relevant follow-up interventions and access to national cancer screening programmes. In addition, in order to understand the impact of the health checks and provide rapid and ongoing policy evaluation, it is important to understand physical health outcomes. Patient-level information is required to monitor these outcomes.

Purpose and outline

The purpose is to calculate, report and pay for activity undertaken in line with contractual agreement.

How this service is commissioned and provided

NHS England service specification, guidance and technical requirements will be published at: https://www.england.nhs.uk/gp/investment/gp-contract/

Information about this service:

  • Participation only in CQRS
  • Quality service start date: 1 April 2019
  • Quality service end date: 31 March 2029
  • Collection frequency: Annually

Service user guides

The Calculating Quality Reporting Service (CQRS) user guides describe how to participate, manually enter and declare achievement for this service. Activity and achievement should be recorded monthly.

Pneumococcal Polysaccharide Vaccination (PPV) Vaccination Programme 2025-2026

Purpose and outline

The pneumococcal vaccines protect against pneumococcal infections caused by the bacterium Streptococcus pneumonia. The pneumococcus is one of the most frequently reported causes of bacteraemia and meningitis and it is the commonest cause of community-acquired pneumonia.

Invasive pneumococcal disease is a major cause of morbidity and mortality and can affect anyone. However, it particularly affects the very young, the elderly and those with impaired immunity or chronic conditions.

This programme delivers vaccinations for patients aged 65 or over and at-risk patients aged 2 years to 64 years inclusive.

PPV is the only vaccine recommended for the patients eligible under this programme (PCV if for smaller children) and only one dose is required per patient which provides life-time cover. For a small number of at-risk patients, vaccination every five years is required.

Practices are only paid for vaccinations carried out by the practice, not for those given by other providers.

How this service is commissioned and provided

Regions commission this service from GP practices.

NHS England service specifications

2025/26: Information about this service

Quality service start date: 1 April 2025

Quality service end date: 31 March 2026

Payment period: Monthly

Collection frequency: Monthly

Manual or automatic entry: Automatic data collection

Included in data collection: All system suppliers (TPP, Medicus and EMIS)

System type: Vaccination and Immunisation (V&I)

Service user guides

The Calculating Quality Reporting Service (CQRS) user guides describe how to participate, manually enter and declare achievement for this service.